E18G (p.Glu18Gly) variant of ACTN2 (Alpha-actinin-2)

E18G (p.Glu18Gly) in ACTN2 (Alpha-actinin-2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.

E18G (p.Glu18Gly) variant details